The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study

The optimal antithrombotic strategy for post-stroke patients with atrial fibrillation and extracranial artery stenosis—a nationwide cohort study

Abstract Background In post-stroke atrial fibrillation (AF) patients who have indications for both oral anticoagulant (OAC) and antiplatelet agent (AP), e.g., those with carotid artery stenosis, there is debate over the best antithrombotic strategy. We aimed to compare the risks of ischemic stroke,...

Full description

Bibliographic Details
Main Authors: Chuan-Tsai Tsai, Yi-Hsin Chan, Jo-Nan Liao, Tzeng-Ji Chen, Gregory Y. H. Lip, Shih-Ann Chen, Tze-Fan Chao
Format: Article
Language:English
Published: BMC 2024-03-01
Series:BMC Medicine
Subjects:
Atrial fibrillation
Warfarin
NOAC
Stroke
Net clinical benefit
Online Access:https://doi.org/10.1186/s12916-024-03338-7

Internet

https://doi.org/10.1186/s12916-024-03338-7

Similar Items